FDA Approves Darolutamide Tablets for Metastatic Hormone-Sensitive Prostate Cancer
darolutamide tablets in combination with docetaxel for adult patients with metastatic hormone-sensitive prostate cancer (mHSPC), FDA approval of darolutamide tablets in combination with docetaxel, ARASENS trial, Nubeqa, Bayer HealthCare Pharmaceuticals Inc.